---
phase: 01-fundacao-e-template
verified: 2026-03-12T00:00:00Z
status: human_needed
score: 7/7 must-haves verified (automated); 2 items require human review
re_verification: false
human_verification:
  - test: "Verify Tai Chi evidence citation is OA-specific"
    expected: "Primary citation for Tai Chi should be an OA-specific systematic review or RCT (e.g., Wang C et al. N Engl J Med 2010 is for fibromyalgia; Lauche R et al. is for rheumatoid arthritis). The annotation claims Nivel A (CEBM 1) but the cited sources do not support this for OA."
    why_human: "Requires literature search to identify the correct OA-specific Tai Chi review (e.g., Cochrane Tai Chi for OA, or Li F et al. osteoarthritis RCT) and correct the citation. Cannot be resolved by automated grep."
  - test: "Clinical dosage accuracy review"
    expected: "A qualified geriatric physiotherapist confirms all frailty-stratified dosage parameters (load percentages, sets, reps, RPE thresholds, progression rates) are clinically appropriate for geriatric OA patients at each frailty tier and align with OARSI 2019 and ACR 2022 recommendations."
    why_human: "Dosage values require clinical domain expertise and cross-referencing against source RCT protocols. Automated checks cannot assess whether 60% 1RM for Robusto patients is clinically sound."
---

# Phase 1: Fundacao e Template — Verification Report

**Phase Goal:** The Shared Foundation Layer exists and P-01 Osteoartrite is a clinically complete, validated protocol that serves as the template for all 19 subsequent protocols — locking document structure, assessment standards, dosage format, evidence grading, safety architecture, and Brazilian Portuguese tool citations.
**Verified:** 2026-03-12
**Status:** human_needed (all automated checks passed; 2 items flagged for human review)
**Re-verification:** No — initial verification

---

## Goal Achievement

### Observable Truths (from ROADMAP.md Success Criteria)

| # | Truth | Status | Evidence |
|---|-------|--------|----------|
| 1 | A Shared Foundation Layer document exists defining: universal baseline battery (TUG, SPPB, Manual Dynamometry) with age-stratified normative values and MCIDs, progression principle, Oxford CEBM grading, and cross-reference index skeleton | VERIFIED | `protocols/SHARED-FOUNDATION.md` — 602 lines; all 8 sections present with normative tables, MCIDs, source PMIDs, Oxford CEBM table, and 20-protocol index shell |
| 2 | P-01 Osteoartrite is a complete TIDieR/CERT-structured document in Brazilian Portuguese with all 8 clinical validity questions answered unambiguously | VERIFIED | `protocols/P-01-OSTEOARTRITE.md` — 1069 lines; Section 15 explicitly indexes all 8 clinical validity questions to their sections; TIDieR/CERT declaration at line 12 and footer |
| 3 | The two-column dosage format with frailty-stratified tables is operational and verified in P-01 | VERIFIED | 7+ dosage tables found at lines 472, 497, 530, 635, 665, 688, 761, 791 — all use format "Robusto/Pre-fragil/Fragil — Valor Rec. / Faixa Aceitavel" |
| 4 | All outcome tools cited in Brazilian Portuguese validated versions (SPPB-BR, WOMAC-BR, MoCA-BR, ODI-BR) with validation citations confirmed | VERIFIED | SHARED-FOUNDATION.md Section 6: SPPB-BR (Nakano 2007 ICC=0.83), WOMAC-BR (Oliveira et al. 2022 PMC9673866), MoCA-BR (Memoria et al. 2013 PubMed 22368034), ODI-BR (Vigatto et al. 2007 PubMed 17304141) — all with peer-reviewed citations |
| 5 | P-01 can be handed to a clinician who then knows exactly which patients qualify, what to prescribe, how to progress them, and when to escalate — without needing any other document | VERIFIED | ACR diagnostic criteria for knee/hip/hands (Sections 1.1–1.3); assessment battery reproduced inline (Section 2); frailty classification inline (Section 2.4); safety architecture complete (Sections 8–11); dosage tables present for all interventions across all 3 phases |
| 6 | Interventions classified by Therapeutic Modality, Manual Therapy, Kinesiotherapy (STRUC-04) | VERIFIED | Each of the 3 phases (Sections 5.4, 6.4, 7.4) contains subsections A) Modalidade Terapeutica, B) Terapia Manual, C) Cinesioterapia |
| 7 | Phase transitions governed by functional criteria (not time alone) | VERIFIED | Section 4 explicitly states the rule ("nunca exclusivamente pelo numero de semanas"); Sections 5.3, 6.3, 7.3 list objective functional benchmarks (NRS, TUG, SPPB scores, WOMAC improvement percentage) |

**Score:** 7/7 truths verified (automated)

---

## Required Artifacts

| Artifact | Expected | Level 1: Exists | Level 2: Substantive | Level 3: Wired | Status |
|----------|----------|----------------|---------------------|----------------|--------|
| `protocols/SHARED-FOUNDATION.md` | Universal standards document for all 20 protocols | Yes (602 lines) | Yes — 8 complete sections with clinical content, normative tables, safety templates | Yes — SPPB score referenced in frailty threshold; frailty tiers feed dosage template | VERIFIED |
| `protocols/P-01-OSTEOARTRITE.md` | Complete template protocol for Osteoarthritis | Yes (1069 lines) | Yes — 15 sections covering all clinical validity questions, interventions, safety, outcomes, references | Yes — Foundation Layer standards reproduced inline; dosage format, frailty rows, NRS thresholds, BR-suffixed tools all present | VERIFIED |

---

## Key Link Verification

| From | To | Via | Status | Details |
|------|----|-----|--------|---------|
| SHARED-FOUNDATION.md Section 1 (Battery) | SHARED-FOUNDATION.md Section 2 (Frailty) | SPPB score feeds frailty threshold — pattern: `SPPB.*fragil` | VERIFIED | Line 114: "SPPB ≤ 9 = alta probabilidade de fragilidade"; Section 2.4 explicitly links SPPB score to frailty classification flow |
| SHARED-FOUNDATION.md Section 2 (Frailty) | SHARED-FOUNDATION.md Section 5 (Dosage Format) | Frailty classification determines dosage row — pattern: `Robusto.*Pre-fragil.*Fragil` | VERIFIED | Section 5.3 "Instrucoes de Uso" steps 2–3 explicitly instruct: classify frailty, then select corresponding column in table |
| P-01-OSTEOARTRITE.md (Assessment) | SHARED-FOUNDATION.md (Battery) | References Foundation battery inline — pattern: `TUG.*SPPB-BR.*Dinamometria` | VERIFIED | Line 285: "Aplicar TUG + SPPB-BR + Dinamometria" with full protocols reproduced inline in Section 2 |
| P-01-OSTEOARTRITE.md (Dosage tables) | SHARED-FOUNDATION.md (Dosage Format) | Two-column frailty-stratified format — pattern: `Robusto.*Pre-fragil.*Fragil.*Valor Recomendado` | VERIFIED | 7+ tables confirmed using identical column structure defined in Foundation Layer Section 5 |
| P-01-OSTEOARTRITE.md (Safety) | SHARED-FOUNDATION.md (Safety Architecture) | NRS thresholds, red flags, polypharmacy, cardiorespiratory reproduced inline | VERIFIED | Section 8 (NRS table 3 phases), Section 9 (11 red flags), Section 10 (7 drug classes), Section 11 (cardiorespiratory precautions with ICC/DPOC adaptation) — all present inline |

---

## Requirements Coverage

| Requirement | Source Plan | Description | Status | Evidence |
|-------------|------------|-------------|--------|---------|
| STRUC-01 | 01-02 | Diagnostic/inclusion criteria defining exactly which patients qualify | SATISFIED | P-01 Sections 1.1–1.3: ACR criteria for knee, hip, and hands; Section 1.2 inclusion; Section 1.3 exclusion with 8 conditions |
| STRUC-02 | 01-02 | Contraindications, precautions, red flags with stopping rules | SATISFIED | P-01 Sections 8 (NRS stopping thresholds), 9 (11 red flags with escalation), 11 (cardiorespiratory stop indicators) |
| STRUC-03 | 01-02 | Flexible phase structure (2-4 phases) with function-based entry/exit criteria | SATISFIED | P-01 Sections 5.1/5.3, 6.1/6.3, 7.1/7.3 — 3 phases, all entry/exit criteria are objective functional measurements |
| STRUC-04 | 01-02 | Interventions classified by Therapeutic Modality, Manual Therapy, Kinesiotherapy | SATISFIED | P-01 Sections 5.4.A/B/C, 6.4.A/B/C, 7.4.A/B/C — explicit subsection classification in each phase |
| STRUC-05 | 01-01 | Shared Foundation Layer document created before any individual protocol | SATISFIED | SHARED-FOUNDATION.md exists with all 8 sections; created in plan 01-01 before 01-02 (P-01) |
| ASMNT-01 | 01-01 | Universal baseline battery (TUG, SPPB, Manual Dynamometry) with age-stratified normative values and MCIDs | SATISFIED | SHARED-FOUNDATION.md Sections 1.1–1.3: normative tables, MCIDs, PMIDs; reproduced inline in P-01 Section 2 |
| ASMNT-02 | 01-02 | Primary outcome indicators per phase with re-evaluation schedule | SATISFIED | P-01 Section 12.2: calendar table (WOMAC-BR, SPPB-BR, TUG, Dinamometria) with frequency and decision thresholds |
| ASMNT-03 | 01-02 | Functional benchmark targets at phase transitions | SATISFIED | P-01 Sections 5.3, 6.3, 7.3 — each with explicit functional exit criteria table |
| ASMNT-04 | 01-01 | All outcome tools cited in Brazilian Portuguese validated versions | SATISFIED | SHARED-FOUNDATION.md Section 6: SPPB-BR, WOMAC-BR, MoCA-BR, ODI-BR — all with -BR suffix and peer-reviewed validation citations |
| DOSE-01 | 01-01 | Two-column dosage format: recommended value + acceptable clinical range | SATISFIED | SHARED-FOUNDATION.md Section 5.1: format specification; Section 5.2: full template example; P-01: applied to all 7+ exercise prescriptions |
| DOSE-02 | 01-01 | "Start low, go slow, but reach the goal" principle embedded | SATISFIED | SHARED-FOUNDATION.md Section 3: full operational definition with 3 components and frailty-tier RPE criteria; P-01 header and Section 2.4 flow |
| DOSE-03 | 01-01 | Frailty-stratified dosage tables (Robust / Pre-frail / Frail) | SATISFIED | SHARED-FOUNDATION.md Section 5.2: template; P-01: all dosage tables use 3-row frailty stratification |
| DOSE-04 | 01-02 | Objective progression criteria, never time-based alone | SATISFIED | P-01 Section 4 rule; functional exit criteria at Sections 5.3, 6.3, 7.3 — each uses objective tool measurements |
| EVID-01 | 01-01 | Evidence level classification per intervention (Oxford CEBM Level A/B/C with primary citation) | SATISFIED | SHARED-FOUNDATION.md Section 4: Oxford CEBM 2011 table with A/B/C mapping and annotation format; P-01: annotation blocks on every intervention — with one exception flagged below |
| EVID-02 | 01-01 | Guideline alignment declaration in every protocol | SATISFIED | P-01 Section 3: OARSI 2019, ACR 2022, AGS/WHO declarations; each intervention annotation cites alignment |
| EVID-03 | 01-01 | Research from PubMed + Cochrane + PEDro triad | SATISFIED | SHARED-FOUNDATION.md Section 4.3: triad specification; P-01 Section 14: references classified by level, drawing from all three sources including PEDro scores |
| SAFE-01 | 01-01 | Pain monitoring with NRS thresholds per phase | SATISFIED | SHARED-FOUNDATION.md Section 7.1: NRS threshold table (3 phases, 3 thresholds each); P-01 Section 8.1: reproduced with OA-specific differentiation |
| SAFE-02 | 01-01 | Structured red flag table with escalation pathways | SATISFIED | SHARED-FOUNDATION.md Section 7.2: 11 red flags with 3-column format; P-01 Section 9.1: 11 entries with escalation destinations |
| SAFE-03 | 01-01 | Polypharmacy interaction section per protocol | SATISFIED | SHARED-FOUNDATION.md Section 7.3: 6 drug classes; P-01 Section 10.1: 7 drug classes (opioids added) with exercise-specific modifications |
| SAFE-04 | 01-01 | Cardiorespiratory precautions section in every protocol | SATISFIED | SHARED-FOUNDATION.md Section 7.4: full template; P-01 Section 11: pre-participation assessment, stop indicators, ICC/DPOC adaptation |
| OUT-01 | 01-02 | Final protocols written in Brazilian Portuguese | SATISFIED | P-01 is entirely in Brazilian Portuguese; header, all clinical content, table headers, footers — no English except PMIDs and proper names |
| OUT-02 | 01-02 | One structured markdown document per comorbidity (20 total) | SATISFIED (1/20) | P-01-OSTEOARTRITE.md is the first of 20; Phase 1 scope is only P-01 |
| OUT-03 | 01-02 | Protocols follow TIDieR/CERT reporting standards | SATISFIED | P-01 line 12 declares TIDieR + CERT; footer cites Hoffmann TC et al. 2014 + Slade SC et al. 2016; structure follows TIDieR items |
| OUT-04 | 01-01/01-02 | Cross-reference index mapping protocol interactions and comorbidity flags | SATISFIED | SHARED-FOUNDATION.md Section 8.1: 20-protocol matrix shell; P-01 row populated with 6 interactions; P-01 Section 13: comorbidity flags |
| PROT-01 | 01-02 | P-01 Osteoartrite (joelho, quadril, coluna, maos) — template protocol | SATISFIED | protocols/P-01-OSTEOARTRITE.md exists, complete, self-contained per Section 15 checklist |

**Coverage:** 25/25 Phase 1 requirements satisfied

---

## Anti-Patterns Found

| File | Line | Pattern | Severity | Impact |
|------|------|---------|----------|--------|
| `protocols/P-01-OSTEOARTRITE.md` | 678 | Tai Chi annotated as "Nivel A (CEBM Nivel 1)" but primary citations are Wang C et al. N Engl J Med 2010 (fibromyalgia RCT) and Lauche R et al. Semin Arthritis Rheum 2013 (rheumatoid arthritis / qigong — not OA). Inline note reads "buscar revisao especifica de Tai Chi para OA" | Warning — incomplete citation | The evidence level annotation for Tai Chi cannot be Nivel A without an OA-specific systematic review or RCT. Tai Chi is correctly included per ACR 2022 strong recommendation for OA of the knee, but the supporting citation needs to be replaced with an OA-specific source (e.g., Song R et al. for knee OA, or the ACR 2022 guideline itself as supporting reference). The inline note reveals this was intentionally deferred during authorship. |

**No other anti-patterns found.** No `return null`, empty implementations, or other stub patterns apply to this documentation project. The single citation issue above is the only substantive gap.

---

## Human Verification Required

### 1. Tai Chi Evidence Citation Correction

**Test:** Search PubMed/Cochrane for Tai Chi + osteoarthritis systematic review or RCT with CEBM Level 1 evidence (e.g., Song R et al., Li F et al., or a Cochrane review on mind-body exercise for OA).
**Expected:** Replace the fibromyalgia and RA citations at P-01-OSTEOARTRITE.md line 678 with an OA-specific primary citation. If no CEBM Level 1 evidence exists for Tai Chi in OA specifically, downgrade annotation to Nivel B and update accordingly.
**Why human:** Requires a literature search and clinical judgment to determine the correct evidence level. Automated grep cannot identify the appropriate OA-specific citation.

### 2. Clinical Dosage Accuracy Review

**Test:** A qualified geriatric physiotherapist reviews all frailty-stratified dosage tables in P-01 (Sections 5.4.C, 6.4.C, 7.4.C) against OARSI 2019 (Bannuru et al.) and ACR 2022 parameters. Particular attention to: initial load percentages (60% / 40% / 30% 1RM), progression rates (+5% / +2.5-5% / +2.5%), RPE thresholds per tier, and aquatic exercise temperature and depth parameters.
**Expected:** All dosage parameters fall within the clinically accepted range for the respective frailty tier and align with the cited evidence base.
**Why human:** Dosage accuracy requires clinical domain expertise and cross-referencing against source RCT protocols. Automated tools cannot assess whether specific numerical values are clinically appropriate.

---

## Gaps Summary

No automated gaps found. Both artifacts exist, are substantive (602 and 1069 lines respectively), and are fully wired. All 25 Phase 1 requirement IDs are satisfied in the actual codebase.

The single anti-pattern (Tai Chi citation mismatch at P-01 line 678) is classified as a warning rather than a blocker because:
1. The intervention itself (Tai Chi) is correctly included per ACR 2022 strong recommendation
2. The note "buscar revisao especifica de Tai Chi para OA" was left intentionally by the author, indicating awareness
3. The impact is localized to one citation block within one subsection of Cinesioterapia in Phase 2
4. The clinical prescription (dosage table, frailty stratification, classification under Cinesioterapia) remains correct

Correction is required before the document is used clinically, but does not block the overall Phase 1 goal of establishing a reusable foundation and complete template protocol.

The two human verification items (Tai Chi citation fix + dosage accuracy review) must be resolved before Phase 1 can be considered fully production-ready.

---

*Verified: 2026-03-12*
*Verifier: Claude (gsd-verifier)*
